- Recent Funding
- Investors
- Roivant Sciences
Roivant Sciences portfolio
Roivant Sciences has 1 portfolio company on record at Recent Funding, with 1 investment in the last 12 months.
About this page
Its most recent investment on record is PsiThera's $47.5M Series A round in December 2025, alongside Lightstone Ventures, Eurofarma, Samsara Biocapital and 1 other. That company is in Health and bio.
What Roivant Sciences invests in
- Health and bio · 1 · 100%
- Manufacturing and industrial · 1 · 100%
How Roivant Sciences invests
| Stage | Deals | Capital in rounds |
|---|---|---|
| Series A | 1 100% | $47.5M |
Roivant Sciences portfolio companies
| Company | Round with Roivant Sciences | Total raised | Latest raise |
|---|---|---|---|
Health and bio |
Series A · $47.5M | $47.5M | Dec 16, 2025 Series A |
Most frequent co-investors
SSamsara Biocapital1 shared round · last Dec 16, 2025
LLightstone Ventures1 shared round · last Dec 16, 2025
EEurofarma1 shared round · last Dec 16, 2025
YYK Bioventures1 shared round · last Dec 16, 2025
Similar investors
IIzou Partners2 companies · 2 deals in 12 mo
- TThe Ljungstrom Family Office2 companies · 2 deals in 12 mo
OO'Shaughnessy Ventures3 companies · 1 deal in 12 mo
SSide Stage Ventures3 companies
AAble Partners4 companies · 1 deal in 12 mo
BBdc Thrive venture5 companies · 3 deals in 12 mo
Investors whose portfolios on Recent Funding center on the same category (Health and bio).
How this is counted
Share is of the 1 round on Recent Funding that name Roivant Sciences. Rounds with no announced date are left out of the year split, and "round" is a round whose stage is not on file.
Portfolio companies are the companies on Recent Funding with a round that lists Roivant Sciences, which is a subset of its real portfolio. API: /api/v1/investors/roivant-sciences (get a free API key). More: the most active VC firms and new venture capital funds.